β-Cyclodextrin Nanophotosensitizers for Redox-Sensitive Delivery of Chlorin e6
Molecules · 2023
DOI: 10.3390/molecules28217398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Jaewon Jo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gwangju Center, Korea Basic Science Institute, Gwangju 61186, Republic of Korea. Hauptthemen laut MEDLINE: Photochemotherapy, Uterine Cervical Neoplasms, Chlorophyllides, beta-Cyclodextrins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Basic Science Institute.
Abstract (Originalsprache)
The aim of this study is to prepare redox-sensitive nanophotosensitizers for the targeted delivery of chlorin e6 (Ce6) against cervical cancer. For this purpose, Ce6 was conjugated with β-cyclodextrin (bCD) via a disulfide bond, creating nanophotosensitizers that were fabricated for the redox-sensitive delivery of Ce6 against cancer cells. bCD was treated with succinic anhydride to synthesize succinylated bCD (bCDsu). After that, cystamine was attached to the carboxylic end of bCDsu (bCDsu-ss), and the amine end group of bCDsu-ss was conjugated with Ce6 (bCDsu-ss-Ce6). The chemical composition of bCDsu-ss-Ce6 was confirmed with 1H and 13C NMR spectra. bCDsu-ss-Ce6 nanophotosensitizers were fabricated by a dialysis procedure. They formed small particles with an average particle size of 152.0 ± 23.2 nm. The Ce6 release rate from the bCDsu-ss-Ce6 nanophotosensitizers was accelerated by the addition of glutathione (GSH), indicating that the bCDsu-ss-Ce6 nanophotosensitizers have a redox-sensitive photosensitizer delivery capacity. The bCDsu-ss-Ce6 nanophotosensitizers have a low intrinsic cytotoxicity against CCD986Sk human skin fibroblast cells as well as Ce6 alone. However, the bCDsu-ss-Ce6 nanophotosensitizers showed an improved Ce6 uptake ratio, higher reactive oxygen species (ROS) production, and phototoxicity compared to those of Ce6 alone. GSH addition resulted in a higher Ce6 uptake ratio, ROS generation, and phototoxicity than Ce6 alone, indicating that the bCDsu-ss-Ce6 nanophotosensitizers have a redox-sensitive biological activity in vitro against HeLa human cervical cancer cells. In a tumor xenograft model using HeLa cells, the bCDsu-ss-Ce6 nanophotosensitizers efficiently accumulated in the tumor rather than in normal organs. In other words, the fluorescence intensity in tumor tissues was significantly higher than that of other organs, while Ce6 alone did not specifically target tumor tissue. These results indicated a higher anticancer activity of bCDsu-ss-Ce6 nanophotosensitizers, as demonstrated by their efficient inhibition of the growth of tumors in an in vivo animal tumor xenograft study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gwangju Center, Korea Basic Science Institute, Gwangju 61186, Republic of Korea.
- School of Chemical Engineering, Chonnam National University, Gwangju 61186, Republic of Korea.
- Research Center for Environmentally Friendly Agricultural Life Sciences, Jeonnam Bioindustry Foundation, Jeonnam 58275, Republic of Korea.
- Department of Dental Materials, College of Dentistry, Chosun University, Gwangju 61452, Republic of Korea.
- Tyros Biotechnology Inc., 75 Kneeland St. 14 Floors, Boston, MA 02111, USA.
ORCID-Profile: Young-Il Jeong
Förderung
- Korea Basic Science Institute
Zitieren
APA
Jo, J., Kim, J. Y., Yun, J. J., Lee, Y. J., & Jeong, Y. I. (2023). β-Cyclodextrin Nanophotosensitizers for Redox-Sensitive Delivery of Chlorin e6. Molecules. https://doi.org/10.3390/molecules28217398
Vancouver
Jo J, Kim JY, Yun JJ, Lee YJ, Jeong YI. β-Cyclodextrin Nanophotosensitizers for Redox-Sensitive Delivery of Chlorin e6. Molecules. 2023. doi:10.3390/molecules28217398
BibTeX
@article{Jo2023,
author = {Jo, Jaewon and Kim, Ji Yoon and Yun, Je-Jung and Lee, Young Ju and Jeong, Young-Il},
title = {β-Cyclodextrin Nanophotosensitizers for Redox-Sensitive Delivery of Chlorin e6},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28217398}
}
EUVIMED